Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-07
2011-11-01
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S120000, C544S333000, C544S407000, C548S125000, C548S202000, C548S254000, C548S255000, C548S444000, C548S503000, C548S518000, C549S398000, C585S026000
Reexamination Certificate
active
08048886
ABSTRACT:
The present invention relates to novel IAP inhibitor compounds of formula I:
REFERENCES:
patent: WO 2006/017295 (2006-02-01), None
patent: WO 2006/133147 (2006-12-01), None
patent: WO 2007/101347 (2007-09-01), None
Chen Ming
Chen Zhuoliang
Straub Christopher Sean
Wang Run-Ming David
Zawel Leigh
Novartis AG
Willis Douglas M
Wilson James O
LandOfFree
Substituted pyrazine-3-one-derivatives as IAP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazine-3-one-derivatives as IAP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazine-3-one-derivatives as IAP inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287505